Concepedia

Author

Clelia Donisi

University of Cagliari

Also Known As

C Donisi, C. Donisi, Clelia Donisi

73

Publications

902

Citations

13

H-Index

16

Concepts

All Affiliations

University of CagliariFondazione IRCCS Istituto Nazionale dei TumoriUniversità Campus Bio-MedicoAzienda Ospedaliero-Universitaria CagliariSapienza University of Rome
CD

About

Clelia Donisi is an author at University of Cagliari specializing in immunotherapy, immunology, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

109

2

Immunology

2

2

109

3

Immunotherapy

2

2

109

4

Cell Biology

1

1

27

5

Clinical Epidemiology

1

1

82

Clelia Donisi

×

9

Publications

304

Citations

9

H-Index

YearCitations

Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes

Alessio Cortellini, Alex Friedlaender, Giuseppe Luigi Banna,

Clinical Lung Cancer

2020

82

The lung immuno-oncology prognostic score (LIPS-3): a prognostic classification of patients receiving first-line pembrolizumab for PD-L1 ≥ 50% advanced non-small-cell lung cancer

Giuseppe Luigi Banna, Alessio Cortellini, Diego Cortinovis,

ESMO Open

2021

61

Smoking status during first‐line immunotherapy and chemotherapy in <scp>NSCLC</scp> patients: A case–control matched analysis from a large multicenter study

Alessio Cortellini, Andrea De Giglio, Katia Cannita,

Thoracic Cancer

2021

47

Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer

Clelia Madeddu, Sı́lvia Busquets, Clelia Donisi,

Cancers

2023

40

Immunotherapy and Cancer: The Multi-Omics Perspective

Clelia Donisi, Andrea Pretta, Valeria Pusceddu,

International Journal of Molecular Sciences

2024

27

Clinical score for colorectal cancer patients with lung-limited metastases undergoing surgical resection: Meta-Lung Score

Pina Ziranu, Paolo Albino Ferrari, Francesco Guerrera,

Lung Cancer

2023

15

CDX-2 expression correlates with clinical outcomes in MSI-H metastatic colorectal cancer patients receiving immune checkpoint inhibitors

Pina Ziranu, Andrea Pretta, Marta Pozzari,

Scientific Reports

2023

12

Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients

Stefano Mariani, Marco Puzzoni, Riccardo Giampieri,

Frontiers in Oncology

2022

10

Mismatch Repair system protein deficiency as a resistance factor for locally advanced rectal adenocarcinoma patients receiving neoadjuvant chemo-radiotherapy

Andrea Pretta, Pina Ziranu, Riccardo Giampieri,

British Journal of Cancer

2023

10

Page 1